Abstract
To evaluate the pharmacokinetics, safety and bioequivalence of the test drug product Duonica® (INN: doxylamine + pyridoxine), enteric-coated tablets, 10 mg + 10 mg (Valenta Pharm JSC, Russia), and the reference drug product Diclectin®, delayed release tablets, 10 mg + 10 mg (Duchesnay Inc., Canada).
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
